Emergencies
Conditions
Keywords
COVID 19, aspecific respiratory symptomatology
Brief summary
This research aims to improve knowledge of the epidemiology of patients consulting in the COvid Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in intermediate patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. It will be necessary to identify the diagnosis of the dyspneic patient and to define his virological status COVID before referring him to the appropriate units. The investigatory propose an original strategy of dedicating entire care sectors to the care of patients admitted for dyspnea in our ER. These units will be named RECOP units. This study would improve epidemiological knowledge of COVID-19 and ability to receive these patients within the SU.
Interventions
OTHERRECOP unit patient
All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified. 30 days after inclusion, virological status and mortality will be collect
Sponsors
University Hospital, Toulouse
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients over the age of 15 admitted to the RECOP unit for dyspnea
Exclusion criteria
* Patient admitted to shock for respiratory distress requiring immediate respiratory support. * Patient under justice safeguard
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Describe the characteristics of patients admitted to reCOP units according to their virological status vis-à-vis COVID-19 | 30 days | The virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Develop a predictive model of the risk of being COVID for patients admitted to the emergency room for dyspnea | 0 days | demographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor |
Other
| Measure | Time frame | Description |
|---|---|---|
| Virological status | 30 days | Virological status will be collected by a phone call at the patient |
| Mortality status | 30 days | Mortality status will be collected by a phone call at the patient |
Countries
France
Outcome results
None listed